Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-17MLYS144Rodman David Malcom plan to sell securities of Mineralys Therapeutics, Inc. under Form 144MEDIUM
Rodman David Malcom filed Form 144 to notify SEC of plan to sell 4584 units of Mineralys Therapeutics, Inc. securities around 2026-06-17, with aggregate market value of $114,600.00. The total outstanding units is 82498101.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions ...
Mid CapBiotechnology
2026-06-17NKTR144ROBIN HOWARD W plan to sell securities of NEKTAR THERAPEUTICS under Form 144MEDIUM
ROBIN HOWARD W filed Form 144 to notify SEC of plan to sell 10000 units of NEKTAR THERAPEUTICS securities around 2026-06-17, with aggregate market value of $602,700.00. The total outstanding units is 33786032.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in past 3 mon...
Mid CapBiotechnology
2026-06-17CRNX144STEPHANIE OKEY plan to sell securities of Crinetics Pharmaceuticals, Inc. under Form 144MEDIUM
STEPHANIE OKEY filed Form 144 to notify SEC of plan to sell 6900 units of Crinetics Pharmaceuticals, Inc. securities around 2026-06-17, with aggregate market value of $241,500.00. The total outstanding units is 105440208.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Mid CapBiotechnology
2026-06-17PTCT144Utter Christine Marie plan to sell securities of PTC THERAPEUTICS, INC. under Form 144MEDIUM
Utter Christine Marie filed Form 144 to notify SEC of plan to sell 19686 units of PTC THERAPEUTICS, INC. securities around 2026-06-17, with aggregate market value of $1,487,474.16. The total outstanding units is 82949338.0. The amount planned to be sold represents 0.02% of total outstanding units; ...
Mid CapBiotechnology
2026-06-17ABOS144DERRELL PORTER plan to sell securities of ACUMEN PHARMACEUTICALS, INC. under Form 144MEDIUM
DERRELL PORTER filed Form 144 to notify SEC of plan to sell 13040 units of ACUMEN PHARMACEUTICALS, INC. securities around 2026-06-17, with aggregate market value of $30,323.22. The total outstanding units is 72227580.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in pa...
Micro CapBiotechnology
2026-06-17NEKTAR THERAPEUTICS144ROBIN HOWARD W plan to sell securities of NEKTAR THERAPEUTICS under Form 144DuplicateMEDIUM
ROBIN HOWARD W filed Form 144 to notify SEC of plan to sell 10000 units of NEKTAR THERAPEUTICS securities around 2026-06-17, with aggregate market value of $602,700.00. The total outstanding units is 33786032.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in past 3 mon...
Mid CapBiotechnology